Analyst Reco. Savara Inc.

Stocks

SVRA

US8051111016

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 12/06/2026 BST			5-day change	1st Jan Change
5.260 ^USD	-0.19%		+3.34%	-12.77%

06-08	Savara Inc. Announces CFO Changes	CI
06-08	Savara Inc. Announces Step Down of Dave Lowrance as Chief Administrative Officer, Effective July 15, 2026	CI

Analyst Reco.

04-24	Oppenheimer Adjusts Price Target on Savara to $11 From $9, Maintains Outperform Rating	MT
11-14	Oppenheimer Adjusts Price Target on Savara to $9 From $8, Maintains Outperform Rating	MT
08/09/25	Oppenheimer Adjusts Savara Price Target to $8 From $6, Maintains Outperform Rating	MT
15/08/25	Savara Shares Rise After Upgrade From HC Wainwright	MT
15/08/25	HC Wainwright Upgrades Savara to Buy From Neutral, $5 Price Target	MT
15/08/25	Oppenheimer Adjusts Price Target on Savara to $6 From $5, Maintains Outperform Rating	MT
02/06/25	Oppenheimer Adjusts Price Target on Savara to $5 From $15, Maintains Outperform Rating	MT
29/05/25	HC Wainwright Downgrades Savara to Neutral From Buy, Adjusts Price Target to $2 From $6	MT
20/12/24	Wells Fargo Initiates Coverage on Savara With Overweight Rating, $8 Price Target	MT
13/11/24	Savara Shares Fall After Evercore ISI Downgrade	MT
13/11/24	Evercore ISI Downgrades Savara to In Line From Outperform, Adjusts Price Target to $5 From $7	MT
27/06/24	JMP Securities Adjusts Price Target on Savara to $10 From $8, Maintains Market Outperform Rating	MT
27/06/24	Oppenheimer Adjusts Price Target on Savara to $15 From $11, Maintains Outperform Rating	MT
27/06/24	Guggenheim Adjusts Price Target on Savara to $10 From $8, Maintains Buy Rating	MT
27/06/24	HC Wainwright Raises Savara Price Target to $10 From $6, Maintains Buy Rating	MT
21/05/24	Oppenheimer Adjusts Savara Price Target to $11 From $9.50, Maintains Outperform Rating	MT
04/03/24	Piper Sandler Adjusts Price Target on Savara to $16 From $7, Maintains Overweight Rating	MT
15/02/24	JMP Securities Starts Savara With Market Outperform Rating, $8 Price Target	MT
07/11/23	Guggenheim Starts Savara With Buy Rating, $7 Price Target	MT
14/08/23	HC Wainwright Adjusts Price Target on Savara to $6 From $3, Keeps Buy Rating	MT
03/04/23	Jefferies Downgrades Savara to Hold From Buy With $2 Price Target	MT
16/03/21	SAVARA : Piper Sandler Starts Savara at Overweight With $7 Price Target	MT
15/03/21	SAVARA : Oppenheimer Initiates Savara at Outperform With $4 Price Target	MT
15/12/20	SAVARA : HC Wainwright Adjusts Savara's Price Target to $3 From $6, Keeps at Buy	MT